Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
- Conditions
- Atrial FibrillationRivaroxabanElderlyRenal Insufficiency
- First Posted Date
- 2019-09-20
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1200
- Registration Number
- NCT04096547
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
tDCS for Multiple System Atrophy With Cerebellar Feature
Not Applicable
- Conditions
- Multiple System Atrophy, Cerebellar Variant (Disorder)
- Interventions
- Device: transcranial direct current stimulation
- First Posted Date
- 2019-09-17
- Last Posted Date
- 2019-09-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04092556
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Completed
- Conditions
- Mantle Cell Lymphoma
- First Posted Date
- 2019-08-20
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 88
- Registration Number
- NCT04061850
- Locations
- π°π·
81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea, Seoul, Korea, Republic of
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea
- Conditions
- Follicular Lymphoma
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2019-08-07
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04048395
- Locations
- π°π·
81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea, Seoul, Korea, Republic of
Timely Acquirement of 12-lead ECG Using Patchy-type Wireless Device Among Patient With Chest Pain
Not Applicable
Completed
- Conditions
- ElectrocardiographyChest Pain
- Interventions
- Device: patchy-type wireless 12-lead ECG
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2020-10-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT04048733
- Locations
- π°π·
Samsung Medical Center, Seoul, Gangnam, Korea, Republic of
A Single-institutional Study to Assess the Time Efficiency and Working Satisfaction Using ANDY(Automatic Needle Destroyer)
Not Applicable
Completed
- Conditions
- Needle Stick Injuries
- Interventions
- Device: Removal of needle with using ANDYs
- First Posted Date
- 2019-07-31
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 129
- Registration Number
- NCT04039906
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Individualized Transcranial Direct Current Stimulation for Gait Function in Healthy Subjects
Not Applicable
Terminated
- Conditions
- Healthy AgingHealthy Adults
- Interventions
- Device: Conventional transcranial direct current stimulationDevice: Individualized transcranial direct current stimulation
- First Posted Date
- 2019-07-24
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 19
- Registration Number
- NCT04030793
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Real-time Monitoring of Motor Cortical Activity Induced by Low-frequency Repetitive Transcranial Magnetic Stimulation
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: only low frequency rTMSDevice: low frequency rTMS + Navigation SystemDevice: Sham low frequency rTMS + Navigation System
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2020-02-27
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT04019028
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Comparing the Visual Outcome, Visual Quality, and Satisfaction Among Three Types of Multi-focal Intraocular Lenses
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: Mix-and-MatchDevice: TrifocalDevice: EDOF
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2022-05-13
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT04019691
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion
Phase 4
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: Dual antiplatelet therapy with a P2Y12 inhibitor plus aspirin
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2024-08-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 3500
- Registration Number
- NCT04014803
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2025. All Rights Reserved by MedPath